Marc Becker

Mar 10, 2016

CRISPR Therapeutics has appointed Marc Becker as CFO. Prior to joining CRISPR Therapeutics, Becker served as CFO and senior vice president of rEVO Biologics. Before rEVO, he spent 10 years at Genzyme, where he most recently served as the vice president of finance for the company's renal and endocrine business.